The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of totally implantable venous access port systems (TIVAPS) related adverse events (AEs) in metastatic colorectal cancer (mCRC) patients treated with and without bevacizumab.
Takahiro Tsushima
No relevant relationships to disclose
Keita Mori
No relevant relationships to disclose
Kentaro Yamazaki
No relevant relationships to disclose
Tomomi Hikosaka
No relevant relationships to disclose
Taro Funakoshi
No relevant relationships to disclose
Hiroyuki Tabuse
No relevant relationships to disclose
Satoshi Hamauchi
No relevant relationships to disclose
Akiko Todaka
No relevant relationships to disclose
Tomoya Yokota
No relevant relationships to disclose
Nozomu Machida
No relevant relationships to disclose
Akira Fukutomi
No relevant relationships to disclose
Yusuke Onozawa
No relevant relationships to disclose
Narikazu Boku
No relevant relationships to disclose
Hirofumi Yasui
No relevant relationships to disclose